Discomfort of the critically ill paediatric patient and correlated variables

Alejandro Bosch-Alcaraz1, Iolanda Jordan2, Llúcia Benito-Aracil3

  • 1Pediatric Nurse, Hospital Sant Joan de Déu, Barcelona, Spain; Department of Public Health, Mental Health, and Maternity/Childhood Nursing, School of Nursing, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.

Insights

Nearly half of critically ill children in the pediatric intensive care unit experience discomfort. Older age and lack of analgosedation are linked to increased discomfort, highlighting the need for targeted interventions.

Area of Science:

  • Pediatric Critical Care Medicine
  • Nursing Research
  • Pain Management

Background:

  • Critically ill children often undergo invasive procedures causing fear, pain, and discomfort.
  • Assessing and managing discomfort is crucial in pediatric intensive care settings.

Purpose of the Study:

  • To analyze the level of discomfort in pediatric intensive care unit (PICU) patients.
  • To identify sociodemographic and clinical factors influencing discomfort in critically ill children.

Main Methods:

  • A descriptive, observational, cross-sectional study involving 311 children.
  • The COMFORT Behavior Scale-Spanish version was used by critical care nurses to assess discomfort over two days.
  • Data were collected on patient age, length of stay, and analgosedation use.

Main Results:

  • 50.2% of patients experienced discomfort (COMFORT score >10).
  • Older age correlated positively with higher discomfort levels (Rho=0.230, p<0.001).
  • Patients not receiving analgosedation had significantly higher discomfort levels (11.96 ± 2.80) compared to those who did (10.77 ± 2.94).

Conclusions:

  • Half of PICU patients experience discomfort, with age and analgosedation being key influencing factors.
  • Clinical practices should incorporate strategies to alleviate discomfort in critically ill children.
  • Further research into pain and discomfort management in pediatric critical care is warranted.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
155
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
180
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
426
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
684
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
156
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
138